Arrowhead Pharmaceuticals Inc. XNAS: ARWR

Arrowhead Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: Arrowhead Pharmaceuticals Inc.: Is Infosys Ltd. worth buying?
Item: Arrowhead Pharmaceuticals Inc.
Rating: 2.120361
Author: Trendlyne DVM scores

Expensive Rocket

about

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed a...

67.05 -2.54 (-3.65%)

600.63% Gain from 52W Low

1.9M

XNAS Volume

XNAS 23 Jan, 2026 4:30 PM (EST)

Board Meeting

The next board meeting for Arrowhead Pharma Inc is on 05 Feb 2026 for the purpose of Arrowhead Pharmaceuticals Inc First Quarter Earnings Conference Call for 2026 See details

Medium Financial Strength

44.4 / 100

Expensive Valuation

11.5 / 100

Technically Moderately Bullish

69.2 / 100

Expensive Rocket These stocks have good momentum, but are expensive with average financials View Similar Embed DVM

1Yr Price target upside is 22%

12 analysts

Arrowhead Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Arrowhead Pharma Inc Live Stock Price Today, Share Analysis and Chart

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed a...

600.63% Gain from 52W Low

SWOT Analysis

Arrowhead Pharma Inc Live Price Chart